FTRE

#1855
Fortrea Holdings Inc. - Common Stock
15.3 9 USD
+3.57%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
15.39
15.39
년간 변동
3.97
18.67
일일 변동
+3.57%
월간 변동
+46.15%
6달 변화
+23.42%
년간 변동율
+269.95%
이전 종가
14.8 6
Open
15.3 9
저가
15.3 9
High
15.3 9
양
116
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.46 B
  • Employee 14 K
  • Founded 2023
  • CEO Paul R. N. Kirchgraber
  • Website www.fortrea.com
  • Headquarter North Carolina, United States
  • FIGI BBG01GZF9VY6
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-1.6
주가매출액비율
—

Fortrea Holdings Inc. - Common Stock

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates.

뉴스